科学健康资讯 · 内容仅供参考,不替代专业诊疗 联系我们|疾病百科
操作系统

tonix医药控股(tnxp)

2023-05-09 操作系统 本文链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001387131-23-002814  Act: 34  Size: 2 MB 网页链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) ARS Annual Report to Security Holders Accession Number: 0001387131-23-004065  Act: 34  Size: 1 MB 网页链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) 8-K Current report, items 5.02, 8.01, and 9.01 Accession Number: 0001387131-23-002322  Act: 34  Size: 219 KB 网页链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) 8-K Current report, items 3.01, 7.01, 8.01, and 9.01 Accession Number: 0001387131-23-004420  Act: 34  Size: 12 MB 网页链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001839882-23-006928  Size: 5 KB 网页链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) 8-K Current report, items 7.01 and 9.01 Accession Number: 0001387131-23-003379  Act: 34  Size: 9 MB 网页链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001839882-23-004702  Size: 7 KB 网页链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001839882-23-004701  Size: 7 KB 网页链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) 3 Initial statement of beneficial ownership of securities Accession Number: 0001839882-23-006927  Size: 4 KB 网页链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001839882-23-007387  Act: 34  Size: 5 MB 网页链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001387131-23-004129  Act: 34  Size: 7 MB 网页链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) 8-K Current report, items 7.01 and 9.01 Accession Number: 0001387131-23-003690  Act: 34  Size: 11 MB 网页链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) DEF 14A Other definitive proxy statements Accession Number: 0001839882-23-007052  Act: 34  Size: 1 MB 网页链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001839882-23-004703  Size: 7 KB 网页链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001214659-23-002409  Act: 34  Size: 83 KB 网页链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) 8-K Current report, items 7.01 and 9.01 Accession Number: 0001839882-23-004715  Act: 34  Size: 8 MB 网页链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001387131-23-003469  Act: 34  Size: 250 KB 网页链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001387131-23-003377  Act: 34  Size: 7 MB 网页链接

Tonix医药控股(TNXP):

Tonix医药控股(TNXP) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001839882-23-004704  Size: 7 KB 网页链接

本文内容仅供健康科普参考,不能替代专业医疗诊断和治疗建议。如有身体不适,请及时就医并遵从医师指导。

相关阅读